SCHEMBL9540152

SCHEMBL9540152

CN1C(=O)Nc2ccc(Cl)cc2C1c1ccoc1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
BRD4 O60885 1/20 0.42
ATM Q13315 1/20 0.41
ADORA2B P29275 5/20 0.40
ADORA2A P29274 2/20 0.40
CYP3A4 P08684 1/20 0.40
GAA P10253 1/20 0.39
TSHR P16473 2/20 0.38
TP53 P04637 1/20 0.36
PGR P06401 1/20 0.35
USP2 O75604 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
AKR1B1 P15121 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11665099 0.81 MEN1 (0.60) MEN1KMT2ABRD4ATMGAA
SCHEMBL16109476 0.74 TP53 (0.47) MEN1KMT2ABRD4ATMGAA
SCHEMBL5563199 0.69 MDM2 (0.41) MEN1KMT2ABRD4ATMGAA
SCHEMBL5555500 0.69 MEN1 (0.47) MEN1KMT2ABRD4ATMGAA
SCHEMBL5562497 0.69 MEN1 (0.42) MEN1KMT2ABRD4ATMGAA
SCHEMBL16108517 0.67 BRD4 (0.81) BRD4PGR
SCHEMBL16109306 0.65 GAA (0.60) MEN1KMT2ABRD4GAATP53
SCHEMBL11662300 0.65 MEN1 (0.57) MEN1KMT2ABRD4ATMGAA
SCHEMBL11660779 0.65 MEN1 (0.69) MEN1KMT2AATMGAATSHR
SCHEMBL24112733 0.65 PGR (0.69) MEN1KMT2AATMGAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0530994-A1 Quinazoline derivatives as inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1993-03-10 EP disclosed
WO-1993004047-A1 QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE MERCK & CO., INC. (US) 1993-03-04 WO disclosed